John R. Adler, Jr., MD - Is REAL Translational Medicine Compatible with Medical Academia?

John R. Adler, Jr., MD

Dorothy and T. K. Chan Professor Emeritus of Neurosurgery
Stanford University School of Medicine

CEO, Zap Surgical Systems, Inc.
CEO, Cureus, Inc.

Event Date
November 22, 2017 8:00am
Location
G5/119 CSC

 

Carbone Cancer Center Grand Rounds

Is REAL Translational Medicine Compatible with Medical Academia?

Wednesday, November 22, 2017

8:00-8:45 AM

G5/119 CSC

John Adler is CEO of both Zap Surgical Systems and Cureus Inc. Dr. Adler is world-renowned for inventing the CyberKnife and the related field of image-guided radiosurgery.
Dr. Adler has been on the faculty of Stanford University since 1987, being appointed the Dorothy and TK Chan Professor of Neurosurgery and Radiation Oncology in 2007. His entire medical and neurosurgical education happened at Harvard, excepting a one-year fellowship at the Karolinska Institute with Lars Leksell, the “father of radiosurgery”. As an academician, John is the author or co-author on more than 250 peer reviewed articles and book chapters and he serves or has served on the editorial boards of seven different peer reviewed journals.

While creating the CyberKnife, Dr. Adler founded Accuray Inc (NASDAQ: ARAY) in 1992 to commercialize his invention. Up until 2009 he served in varying roles at Accuray including CEO, Chief Medical Officer and Chairman. To date Accuray technology has been used to treat more than one million patients and most modern radiation equipment now incorporates John’s basic idea for image-guided targeting. In 2002 Dr. Adler founded the CyberKnife Society, later (2012) renamed the Radiosurgical Society. In 2014 Dr. Adler founded Zap Surgical Systems in Silicon Valley with a mission to “Advance Cancer Treatment for All Humanity”. John also serves as Editor-in-Chief of Cureus.com, the world’s only multi-disciplinary free open access medical journal, which he founded in 2012.